Presentations

15:30

Edge-AI-enabled Aptamer Impedance Biosensor for Real-time Point-of-care Tacrolimus Therapeutic Drug Monitoring

Juhan Lee (KR)

Bio Abstract

15:40

A clinical study on the reduction of donor lymphocyte chimerism rate in recipient tissues after liver transplantation by extracorporeal perfusion of anti-thymocyte globulin via portal vein

Jinzhen Cai (CN)

Bio Abstract

15:50

10-year analysis of low-Tacrolimus/Everolimus versus regular triple therapy for elderly recipients. The nEVERold trial

Elias David-Neto (BR)

Bio Abstract

15:57

Proton-pump inhibitors: an opportunity for deprescribing in the solid organ transplant population

Anna Posthumus (NL)

Bio Abstract

16:04

Building model-informed precision dosing platforms for tacrolimus in lung, heart and bone marrow transplantation

Dirk Kuypers (BE)

Bio Abstract

16:11

An algorithm-driven predictive strategy for personalized tacrolimus dosing in kidney transplant recipients

Guodong Chen (CN)

Bio Abstract

16:16

Balanced Electrolyte Solutions in Kidney Transplantation: CARI Guidelines Evidence-Based Recommendations for Improved Outcomes:

David Tunnicliffe (AU)

Bio Abstract

16:21

Efficacy and safety of low dose trimethoprim-sulfamethoxazole for pneumocystis jirovecii pneumonia in kidney transplant recipients: a retrospective cohort study

Xuqin Jiang (CN)

Bio Abstract